While previous studies have shown that MyD88 expression in DCs is important for maturation and cross-presentation to T cells21, our results above indicate that MyD88 expression in tumor-associated myeloid cells suppress CD8+ T cell responses to RT dependent on type I IFN. The gene discussed is MYD88; the disease is neoplasm.